Sartorius Stedim Biotech S.A. (SRTOY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Aubagne, France. Der aktuelle CEO ist Rene Faber.
SRTOY hat IPO-Datum 2022-02-09, 9,961 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $210.8B.
Sartorius Stedim Biotech S.A. is a global supplier of instruments, consumables, and services for the biopharmaceutical industry. The company provides a comprehensive portfolio including cell lines, culture media, bioreactors, filtration and purification systems, and single-use bioprocess equipment, as well as data analytics software for optimizing biopharmaceutical development and production. It serves pharmaceutical manufacturers, research laboratories, and producers in the food and chemical industries with solutions spanning cell cultivation, fermentation, purification, and product storage and transportation. Founded in 1870 and headquartered in Aubagne, France, Sartorius Stedim Biotech operates as a subsidiary of Sartorius AG.
